Thursday, April 26, 2018

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure, announced that it has closed a Series C financing of $70 million led by Deerfield Management along with participation from new investors - Endeavour Vision, Quark Venture and Aperture Venture Partners - and all previous major investors, including strategics Johnson & Johnson Innovation and Edwards Lifesciences.CAESAREA, Israel, April 26, 2018 /PRNewswire/ -- V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C...




from PR Newswire: //https://ift.tt/2vQBQRG
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)